Drug Database
PR

prednisolone farnesil (Farnezone / Farnesone / Farnerate)

✓ Approved

SK · NR3C1 · Small Molecule

What is prednisolone farnesil?

prednisolone farnesil is a small molecule developed by SK. It is approved for therapeutic indications via topical.

Drug Profile

Brand NamesFarnezone, Farnesone, Farnerate
CompanySK
Drug ClassSmall Molecule
Molecular TargetNR3C1
RouteTopical
StatusApproved
Sources: ClinicalTrials.gov, SK

Mechanism of Action

Molecular Targets

prednisolone farnesil acts on 1 molecular target:

NR3C1nuclear receptor subfamily 3 group C member 1 (GR, GCCR)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

prednisolone farnesil is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Musculoskeletal and connective tissue disordersRheumatoid arthritis✓ Approved

Related Research Articles

Unable to load articles right now.

Ask about prednisolone farnesil